Long-term Use and Safety of JAK Inhibitors and Evaluating Efficacy Outcomes in Atopic Dermatitis : Episode 12

Video

June 5, 2023

AD Treatment: Upadacitinib

Author(s):

Andrew Blauvelt, MD

Andrew Blauvelt, MD, discusses upadacitinib for the treatment of atopic dermatitis (AD).

EP: 1.Standard of Care in AD

EP: 2.Clinical Outcomes in AD Clinical Trials

EP: 3.EASI Scores in AD Treatment

EP: 4.NRS in AD Treatment

EP: 5.AD: Efficacy Outcomes

EP: 6.RAD 2023 AD Trial: Meta-Analysis Data

EP: 7.AD Clinical Approach: Switching Therapies

EP: 8.Topical and Systemic Treatments for AD

EP: 9.Pathophysiology of AD Treatments

EP: 10.Treatment Selection in AD

EP: 11.JAK Inhibitor Safety

EP: 12.AD Treatment: Upadacitinib

EP: 13.Switching Therapies in AD

Related Videos

3 experts are featured in this series.

3 experts are featured in this series.

3 experts are featured in this series.

3 experts are featured in this series.

Skin of Color Savvy: The Art and Science of Treating Patients of Color

3 experts are featured in this series.

Crisis Point: Benzene Concerns in Acne Care

Discussing FDA Approval of Tapinarof Cream for Atopic Dermatitis, with John Browning, MD

Do Not Sell My Information

Terms & Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2025 MJH Life Sciences

All rights reserved.